NO944247L - Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor - Google Patents

Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor

Info

Publication number
NO944247L
NO944247L NO944247A NO944247A NO944247L NO 944247 L NO944247 L NO 944247L NO 944247 A NO944247 A NO 944247A NO 944247 A NO944247 A NO 944247A NO 944247 L NO944247 L NO 944247L
Authority
NO
Norway
Prior art keywords
receptor
vitamin
transcobalamin
blocking agents
growth blocking
Prior art date
Application number
NO944247A
Other languages
English (en)
Norwegian (no)
Other versions
NO944247D0 (no
Inventor
Jr Alton Charles Morgan
Original Assignee
Receptagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Receptagen Corp filed Critical Receptagen Corp
Publication of NO944247D0 publication Critical patent/NO944247D0/no
Publication of NO944247L publication Critical patent/NO944247L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO944247A 1992-05-08 1994-11-07 Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor NO944247L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88054092A 1992-05-08 1992-05-08
PCT/US1993/004341 WO1993023557A1 (fr) 1992-05-08 1993-05-07 Agents antirecepteurs diriges contre le recepteur de la vitamine b12/transcobalamine ii

Publications (2)

Publication Number Publication Date
NO944247D0 NO944247D0 (no) 1994-11-07
NO944247L true NO944247L (no) 1995-01-09

Family

ID=25376514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944247A NO944247L (no) 1992-05-08 1994-11-07 Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor

Country Status (11)

Country Link
US (1) US5688504A (fr)
EP (1) EP0644948B1 (fr)
JP (1) JPH07508174A (fr)
KR (1) KR950701390A (fr)
AT (1) ATE163679T1 (fr)
AU (1) AU680822B2 (fr)
CA (1) CA2135277C (fr)
DE (1) DE69317282D1 (fr)
NO (1) NO944247L (fr)
NZ (1) NZ252559A (fr)
WO (1) WO1993023557A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416728B2 (en) 1992-05-08 2008-08-26 Kyto Biopharma, Inc. Growth blocking agents
JPH10502334A (ja) * 1994-04-08 1998-03-03 レセプタゲン・コーポレーション 受容体調節剤およびこれに関連した方法
US5869465A (en) * 1994-04-08 1999-02-09 Receptagen Corporation Methods of receptor modulation and uses therefor
US5739287A (en) * 1994-04-08 1998-04-14 University Of Washington Biotinylated cobalamins
US5840880A (en) * 1994-04-08 1998-11-24 Receptagen Corporation Receptor modulating agents
WO1996008515A1 (fr) * 1994-09-13 1996-03-21 Receptagen Corporation Agents antirecepteurs et inhibiteurs de croissance diriges contre les sites de liaison et le recepteur de vitamine b12/transcobalamine ii
EP1015475A1 (fr) * 1995-10-19 2000-07-05 Receptagen Corporation Agents de modulation des recepteurs de la vitamine b 12?
US20020102258A1 (en) * 1997-05-12 2002-08-01 Smithkline Beecham Corporation Human tumor necrosis factor receptor-like 2 (TR2) antibodies
JP2001524985A (ja) * 1997-05-12 2001-12-04 スミスクライン・ビーチャム・コーポレイション ヒト腫瘍壊死因子受容体様２（ｔｒ２）抗体
US6410245B1 (en) * 1998-04-01 2002-06-25 Affymax, Inc. Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
GB9820473D0 (en) * 1998-09-18 1998-11-11 Axis Biochemicals Asa Assay
US6492497B1 (en) * 1999-04-30 2002-12-10 Cambridge Antibody Technology Limited Specific binding members for TGFbeta1
CA2441228A1 (fr) 2001-03-23 2002-10-03 Aphton Corporation Traitement combine du cancer du pancreas
GB0109925D0 (en) * 2001-04-23 2001-06-13 Axis Shield Asa Method
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US20040047917A1 (en) * 2002-09-06 2004-03-11 Stephen Wilson Drug delivery and targeting with vitamin B12 conjugates
EP2567974A3 (fr) 2004-09-22 2013-05-22 Cancer Advances, Inc., Anticorps monoclonaux contre la progastrine
CN101415415A (zh) * 2006-01-23 2009-04-22 约瑟夫·P·埃里科 定向药物开发的方法和组合物
US9044461B2 (en) 2006-04-07 2015-06-02 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
US8524454B2 (en) 2006-04-07 2013-09-03 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
IL271427B2 (en) 2017-06-15 2025-08-01 Cancer Advances Inc Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
WO2025219395A1 (fr) 2024-04-16 2025-10-23 Chu D'angers Traitement de cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4332785A (en) * 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
JPS633262A (ja) * 1986-06-24 1988-01-08 Toshiba Corp 網状赤血球の分析方法及び装置

Also Published As

Publication number Publication date
CA2135277A1 (fr) 1993-11-25
WO1993023557A1 (fr) 1993-11-25
EP0644948B1 (fr) 1998-03-04
AU680822B2 (en) 1997-08-14
AU4239193A (en) 1993-12-13
NO944247D0 (no) 1994-11-07
CA2135277C (fr) 2001-04-24
JPH07508174A (ja) 1995-09-14
NZ252559A (en) 1996-10-28
DE69317282D1 (de) 1998-04-09
EP0644948A1 (fr) 1995-03-29
US5688504A (en) 1997-11-18
ATE163679T1 (de) 1998-03-15
KR950701390A (ko) 1995-03-23

Similar Documents

Publication Publication Date Title
NO944247D0 (no) Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor
FI960567A0 (fi) Monoklonaalinen vasta-aine, joka indusoi apoptoosin
DK0724456T3 (da) CD40-Antistoffer
AR001413A1 (es) Compuestos triciclicos de carbamato, utiles para la inhibición de la función de la proteina g y paratratamiento de enfermedades proliferativas.
AU6914798A (en) Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
EA199700280A1 (ru) Ингибиторы протеинкиназы с
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
YU28897A (sh) Biciklicno kondenzovani piridini
DK0689426T3 (da) Terapeutisk middel til behandling af melanomer
DK0802924T3 (da) Lægemiddel til forlænget immunsuppression og eliminering af tumorceller
AU7657387A (en) Apoprotein b-100 specific monoclonal antibodies
DE59203128D1 (de) Abbrandträger zum abbrennen von explosivstoffen.
AU3683395A (en) Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
TR199900943T2 (xx) Pirimidin t�revlerinin haz�rlanma prosesi.
FR2707171B1 (fr) Pellicule adhésive pour bandage et bandage adhésif utilisant cette pellicule.
WO2002042318A3 (fr) Conjugues fixant les recepteurs de transcobalamine pour therapie par capture de neutrons
NO891713D0 (no) Monoklonale antistoffer til vevplasminogenaktivator (t-pa)
FR2693561B1 (fr) Source de lumière polarisée et rétroprojecteur utilisant cette source.
PT584368E (pt) Utilizacao e processo para a producao de um inibidor de metasteses e um inibidor de adesao celular contendo respectivamente um anticorpo
KR940000965U (ko) 정량 눈새김 연료운반통
UA8309A (uk) Система виявлення лазерного опромінювання
DK240388D0 (da) Paahaengsvogn til transport af skiftelad
KR970706308A (ko) 비타민 B_12/트랜스코발아맨 Ⅱ 수용체 및 결합 부위에 대한 항-수용체 및 성장차단제(Anti-receptor and growth blocking agents to the vitamin B_12/transcobalamin Ⅱ receptor and binding sites)
DK87293D0 (da) Soenderdelingsapparat til selektiv soenderdeling af materialer med forskellig brudstyrke
DE69324928D1 (de) Monoklonaler antikörper